Harvest Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-75,000
Closed -$1.61M 76
2026
Q1
$1.61M Buy
+75,000
New +$1.06M 0.78% 21

Other funds holding DAWN

Harvest Management's DAWN Position: Q2 2026 in Review

Harvest Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 75,000 shares — an estimated $1.61M sold.

Harvest Management first reported a position in DAWN in Q1 2026 and held it in 1 quarter. The position peaked at $1.61M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

  • Harvest Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Harvest Management sold 75,000 Day One Biopharmaceuticals shares in Q2 2026, an estimated $1.61M.
  • Harvest Management first reported a position in Day One Biopharmaceuticals in Q1 2026 and held it in 1 quarter.
  • Harvest Management's Day One Biopharmaceuticals position peaked at $1.61M in Q1 2026.
  • 1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Harvest Management's 13F filing for Q2 2026, filed 14 Aug 2026.